BRAIN Biotech AG gains full ownership of Biocatalysts Ltd
BRAIN Biotech AG has purchased the two remaining minority stakes in Biocatalysts Ltd and accelerates execution of its One-BioProducts Strategy
BRAIN Biotech AG has bought the two remaining minority stakes in Biocatalysts Ltd, Wales. Biocatalysts is now fully owned by BRAIN Biotech AG, the parent company of the BRAIN Biotech Group, and will form the nucleus of the Group’s ambitious growth strategy to create a global multi-niche enzyme champion.
Earlier in the year at their Capital Markets Day BRAIN Biotech announced its One-Bioproducts Strategy and the formation of the BioProducts division under the leadership of Biocatalysts.
For more information in the full press release click below.
Highlights from BRAIN Biotech AG's announcement:
- BRAIN Biotech buys two remaining minority stakes in Biocatalysts Ltd
- Transaction financed from existing cash and from new debt
- All industrial products businesses will now be merged under Biocatalysts' leadership
“Owning 100% of Biocatalysts Ltd builds the prerequisite to concentrate all of our industrial production assets under one strong leadership team. This will enable us to harvest revenue and cost synergies at an accelerated speed.
